Page 16 - Boxed Warning News Today

– Long-Term & Real-World HIV Research Offer Insights into How Treatment with Biktarvy® and Sunlenca® May Help Inform the Future of Coordinated, Person-Centered HIV Care – – Updates on...

Jay is sharing his story of receiving an ADHD diagnosis and eventually finding his treatment approach with Qelbree15.7 million U.S. children, teens and...

Jay is sharing his story of receiving an ADHD diagnosis and eventually finding his treatment approach with Qelbree15.7 million U.S. children, teens and adults estimated to have been diagnosed with...

Brixadi® extended-release subcutaneous injection is now available for the treatment of moderate to severe opioid use disorder.

- Patients who initially experienced limited or no facial or total body repigmentation at six months achieved improved repigmentation after continued treatment with Opzelura for up to two years -...

First Phase 3 survival data from KEYNOTE-A39/EV-302 support potential benefit of combination approach in previously untreated locally advanced or metastatic urothelial cancer; data are selected for...

NEW YORK, Oct. 10, 2023 /PRNewswire/ -- Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that it will...

People are dubbing the psyllium "the poor man's Ozempic" but can it really help with weight loss? Nutrition experts weigh in.

People are dubbing the psyllium "the poor mans Ozempic" but can it really help with weight loss? Nutrition experts weigh in.

(BPT) - Davitria lives with two mental illnesses and tardive dyskinesia.